ATE135049T1 - Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode - Google Patents

Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode

Info

Publication number
ATE135049T1
ATE135049T1 AT88904935T AT88904935T ATE135049T1 AT E135049 T1 ATE135049 T1 AT E135049T1 AT 88904935 T AT88904935 T AT 88904935T AT 88904935 T AT88904935 T AT 88904935T AT E135049 T1 ATE135049 T1 AT E135049T1
Authority
AT
Austria
Prior art keywords
cystatin
producing
carrying
modifications
dna sequence
Prior art date
Application number
AT88904935T
Other languages
English (en)
Inventor
Anders Grubb
Ake Lundwall
Magnus Abrahamson
Henrik Dlaboge
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Application granted granted Critical
Publication of ATE135049T1 publication Critical patent/ATE135049T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/8139—Cysteine protease (E.C. 3.4.22) inhibitors, e.g. cystatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Molecular Biology (AREA)
  • Cardiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Vascular Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Electronic Switches (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT88904935T 1987-05-22 1988-05-20 Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode ATE135049T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK260987A DK260987D0 (da) 1987-05-22 1987-05-22 Fremgangsmaade til fremstilling af et humant protein samt dna-sekvens til anvendelse ved udoevelse af fremgangsmaaden

Publications (1)

Publication Number Publication Date
ATE135049T1 true ATE135049T1 (de) 1996-03-15

Family

ID=8113675

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88904935T ATE135049T1 (de) 1987-05-22 1988-05-20 Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode

Country Status (12)

Country Link
EP (1) EP0362259B1 (de)
JP (1) JP3011274B2 (de)
AT (1) ATE135049T1 (de)
AU (1) AU619750B2 (de)
CA (1) CA1340862C (de)
DE (1) DE3855078T2 (de)
DK (1) DK260987D0 (de)
ES (1) ES2013337A6 (de)
FI (1) FI102191B (de)
IL (1) IL86476A (de)
NO (1) NO301985B1 (de)
WO (1) WO1988009384A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2002820A1 (en) * 1988-11-18 1990-05-18 Kazunori Hanada Pharmaceutical use for cystatins
GB9122051D0 (en) * 1991-10-17 1991-11-27 Univ Nottingham Medicines
GB9403819D0 (en) * 1994-02-28 1994-04-20 Univ Leeds Control of parasites
AU715747B2 (en) * 1994-11-21 2000-02-10 University Of Leeds, The Modified proteinase inhibitors
AU738766B2 (en) * 1994-11-21 2001-09-27 University Of Leeds, The Modified proteinase inhibitors
US6011012A (en) 1995-06-05 2000-01-04 Human Genome Sciences, Inc. Human cystatin E
WO1996039418A1 (en) * 1995-06-05 1996-12-12 Human Genome Sciences, Inc. Human cystatin e
CA2335344A1 (en) * 1998-08-05 2000-02-17 The University Of British Columbia Production and use of modified cystatins
AU2178000A (en) * 1998-12-11 2000-06-26 Salk Institute For Biological Studies, The Co-factors for trophic factors, and methods of use thereof
EP1176200A3 (de) 2000-06-20 2005-01-12 Switch Biotech Aktiengesellschaft Verwendung von Polypeptiden oder diese kodierende Nukleinsäuren zur Diagnose oder Behandlung von Hauterkrankung oder Wundheilung sowie ihre Verwendung zur Indentifizierung von pharmakologisch aktiven Substanzen
JP6203723B2 (ja) * 2012-07-31 2017-09-27 雪印メグミルク株式会社 骨疾患の予防又は治療用タンパク質素材及びその製造方法
CN102895658A (zh) * 2012-08-23 2013-01-30 苏州大学附属第一医院 Cystatin C在治疗蛛网膜下腔出血后发生的脑血管痉挛的应用
CN106119286A (zh) * 2016-08-10 2016-11-16 吴江近岸蛋白质科技有限公司 表达载体及其高效表达和制备人胱抑素c蛋白的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C

Also Published As

Publication number Publication date
EP0362259A1 (de) 1990-04-11
FI102191B1 (fi) 1998-10-30
NO890260D0 (no) 1989-01-20
DE3855078D1 (de) 1996-04-11
WO1988009384A1 (en) 1988-12-01
IL86476A (en) 1994-01-25
ES2013337A6 (es) 1990-05-01
DE3855078T2 (de) 1996-07-18
JPH03501201A (ja) 1991-03-22
DK260987D0 (da) 1987-05-22
NO890260L (no) 1989-01-20
JP3011274B2 (ja) 2000-02-21
FI895553A0 (fi) 1989-11-21
CA1340862C (en) 1999-12-28
IL86476A0 (en) 1988-11-15
EP0362259B1 (de) 1996-03-06
AU619750B2 (en) 1992-02-06
AU1939988A (en) 1988-12-21
NO301985B1 (no) 1998-01-05
FI102191B (fi) 1998-10-30

Similar Documents

Publication Publication Date Title
DE3855078D1 (de) Verfahren zur herstellung von cystatin-c oder abwandlungen davon und dns-sequenz zur ausführung dieser methode
DE68928934D1 (de) Verfahren zur herstellung von menschlicher dnase
DE3888274D1 (de) Vorrichtung zur intensiven und kontrollierten Herstellung von Mikroorganismen durch Photosynthese.
DE3177213D1 (de) Dns-sequenzen, rekombinante dns-molekuele und verfahren zur herstellung von dem menschlichen fibroblast-interferon.
DE3884435D1 (de) Verfahren zur erzeugung hochreinen wassers und verfahren zur verwendung dieses wassers.
PL272698A1 (en) Method for expressing human proapolyprotein a-j
ATE162551T1 (de) Verfahren zur herstellung von dihomo-gamma- linolensäure und das in dieser enthaltende lipid
DE3888048D1 (de) Verfahren zur Herstellung von durchsichtigen Polysiloxanelastomeren.
DE3853824D1 (de) Aktivierter kohlenstoff und verfahren zur herstellung.
ATE163447T1 (de) Verfahren zur herstellung von kollagenfasern
IL107642A0 (en) Progenitor b cell stimulating factor
DE3660494D1 (en) Method for the manufacture of waterproof leather or fur
DE3885151D1 (de) Methode zur Herstellung von Methacrylatestern.
ATE81339T1 (de) Verfahren zur herstellung von zyklischen sulfaten.
DE3767680D1 (de) Methode zur herstellung von adiponitril.
DE68916086D1 (de) Verfahren zur Herstellung von Kohlenstoff/Kohlenstoff-Verbundstoffen.
PT83968A (de) Verfahren zur verbesserung des expression von eukaryontenprotein
ATE91721T1 (de) Verfahren zur herstellung von ibuprofen.
DE3680445D1 (de) Verfahren zur herstellung von mesophilen mikroorganismen, die eine bei hoeherer temperatur aktive d-hydantoinase enthalten.
ATE49185T1 (de) Verfahren zur herstellung von halogen-magnesium- alanat und dessen verwendung.
ATE45968T1 (de) Verfahrung zur herstellung von ungesaettigen polyestern.
ES2125216T3 (es) Procedimiento para la produccion de polipeptidos recombinantes con actividad de hormona porcina del crecimiento.
DE3785266D1 (de) Stamm zur massenproduktion von epsilon-poly-l-lysin, methode, um diesen stamm zu gebrauchen, und methode zur herstellung von epsilon-poly-l-lysin.
DE3786870D1 (de) Methode zur herstellung von proteinen.
DE3884324D1 (de) Verfahren zur Herstellung von menschlichen pro-apolipoprotein-A-I-ähnlichen Proteinen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties